Devansh Mishra’s Latest Research Highlights Hypercoagulable State in COPD
Devansh Mishra, Associate at Trainee Research AssoCiation of KGMU (TRACK), shared a post on LinkedIn:
“New Publication Alert!
Thrilled to share our latest research article, “Evaluation of Prothrombotic Biomarkers in Stable and Exacerbation Phases of Chronic
Obstructive Pulmonary Disease: A Cross-Sectional Study,” published in Cureus.
Chronic Obstructive Pulmonary Disease (COPD) remains a major global health burden, and acute exacerbations (AECOPD) significantly worsen morbidity and mortality. Our study explores the role of prothrombotic biomarkers—fibrinogen, CRP, D-dimer, and vWF—in identifying and differentiating stable and exacerbation phases of COPD.
We found that AECOPD is associated with a distinct hypercoagulable state, emphasizing the growing evidence that inflammation and thrombosis are tightly linked in disease progression. These findings not only shed light on potential diagnostic and prognostic biomarkers but also open pathways for early risk stratification and targeted therapy.
Grateful to my mentors Prof. Virendra Atam sir, Prof. Shyam chand Chaudhary sir, and Dr. Jay Tewari boss for their invaluable guidance and support throughout this work.
Proud to contribute to the evolving understanding of COPD pathophysiology and its clinical management.”
Title: Evaluation of Prothrombotic Biomarkers in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease: A Case-Control Study
Authors: Kamlesh K. Gupta, Shantanu Singh, Virendra Atam, Devansh Mishra, Jay Tewari, Shyam C. Chaudhary, Ajay Patwa
Read full article here
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress
-
Jun 15, 2026, 10:15Carol Bewick: Why the Global Community Makes EHA 2026 Unforgettable
-
Jun 15, 2026, 10:07Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026